While the characterization of the biosynthetic pathway of monoterpene indole alkaloids (MIAs) in leaves of Catharanthus roseus is now reaching completion, only two enzymes from the root counterpart dedicated to tabersonine metabolism have been identified to date, namely tabersonine 19-hydroxylase (T19H) and minovincine 19-O-acetyltransferase (MAT). Albeit the recombinant MAT catalyzes MIA acetylation at low efficiency in vitro, we demonstrated that MAT was inactive when expressed in yeast and in planta, suggesting an alternative function for this enzyme. Therefore, through transcriptomic analysis of periwinkle adventitious roots, several other BAHD acyltransferase candidates were identified based on the correlation of their expression profile with T19H and found to localize in small genomic clusters. Only one, named tabersonine derivative 19-O-acetyltransferase (TAT) was able to acetylate the 19-hydroxytabersonine derivatives from roots, such as minovincinine and h€ orhammericine, following expression in yeast. Kinetic studies also showed that the recombinant TAT was specific for root MIAs and displayed an up to 200-fold higher catalytic efficiency than MAT. In addition, gene expression analysis, protein subcellular localization and heterologous expression in Nicotiana benthamiana were in agreement with the prominent role of TAT in acetylation of root-specific MIAs, thereby redefining the molecular determinants of the root MIA biosynthetic pathway. Finally, identification of TAT provided a convenient tool for metabolic engineering of MIAs in yeast enabling efficiently mixing different biosynthetic modules spatially separated in the whole plant. This combinatorial synthesis associating several enzymes from Catharanthus roseus resulted in the conversion of tabersonine in tailor-made MIAs bearing both leaf and root-type decorations.
INTRODUCTION
Numerous plants from the Apocynaceae, Loganiaceae and Rubiaceae families evolved a specialized metabolism leading to the synthesis of the poisonous monoterpene indole alkaloids (MIAs) that constitute a cornerstone of their defense arsenal (St-Pierre et al., 2013) . For decades, the inherent pharmacological properties of MIAs have been exploited to treat human diseases as exemplified with the antiarrhythmic drug ajmaline, the peripheral vasodilator raubasine and the highly valuable anti-cancer drugs vinblastine and vincristine (van Der Heijden et al., 2004) .
Amongst MIA-producing plants, the Madagascar periwinkle (Catharanthus roseus) is, by far, the most studied since it is still the sole source of the aforementioned antineoplastic MIAs. Over the last 60 years, many research groups have contributed to the elucidation of the MIA biosynthetic pathway and to its organization in planta making this complex specialized metabolism one of the best characterized to date (Courdavault et al., 2014) . Notably, most of this information relates to MIA biosynthesis in leaves, the main accumulation site of vindoline, a precursor of vinblastine/ vincristine (Westekemper et al., 1980) . The formation of vindoline results from the seven-step conversion of tabersonine, beginning with C16 hydroxylation by tabersonine 16-hydroxylase (T16H2, CYP71D351), methylation of this hydroxyl group by 16-hydroxytabersonine 16-O-methyltransferase (16OMT) and a final acetylation by deacetylvindoline 4-O-acetyltransferase (DAT; St-Pierre et al., 1998; Besseau et al., 2013; Qu et al., 2015) (Figure 1 ).
Interestingly, identification of DAT led to defining the class of acyltransferase known as BAHD acyltransferases (BAHDs) according to the name of initially characterized enzymes of this family (BEAT, benzylalcohol O-acetyltransferase; AHCT, anthocyanin O-hydroxycinnamoyltransferase;
HCBT, anthranilate N-hydroxycinnamoyl/ benzoyltransferase; DAT) (St-Pierre et al., 1998; D'Auria, 2006) . BAHDs constitute a large family of enzymes, with around 110 biochemically characterized members, catalyzing acyl-CoA dependent acylations of diverse specialized metabolites such as terpenoids, alkaloids or phenolics. Based on their overall identity, BAHDs have been successively clustered into eight distinct clades displaying either strict of less stringent specifies for CoA thioester donor and for substrates (D'Auria, 2006; Luo et al., 2007; Yu et al., 2009; Tuominen et al., 2011) .
Although MIA biosynthesis is well characterized in C. roseus leaves, data concerning MIA metabolism in roots are scarce. Roots accumulate diverse MIA structural classes such as the iboga-type catharanthine, the heteroyohimbine, ajmalicine and serpentine and various aspidosperma MIAs including the tabersonine derivatives 19-O-acetylh€ orhammericine and echitovenine (Laflamme et al., 2001; Ferreres et al., 2010) . Enzymes involved in heteroyohimbine synthesis have been recently described (Stavrinides et al., 2015 (Stavrinides et al., , 2016 . The synthesis of 19-O-acetylh€ orhammericine and echitovenine results from three sequential reactions involving either a 6,7-epoxidation or 6,7-reduction, a C19 hydroxylation and 19-O-acetylation ( Figure 1) . While the precise reaction sequence has not been solved, two enzymes from this pathway have been described: tabersonine 19-hydroxylase (T19H, CYP71BJ1) and minovincinine 19-hydroxy-O-acetyltransferase (MAT) (Laflamme et al., 2001; Giddings et al., 2011) . In addition, an activity for 6,7-epoxidation has been characterized as a P450 enzyme (Rodriguez et al., 2003) .
With the aim to initiate the bio-engineered production of root MIAs in heterologous organisms as reported for strictosidine and vindoline (Miettinen et al., 2014; Brown et al., 2015; Qu et al., 2015) , we reinvestigated in this work the acetylation reactions of 19-hydroxytabersonine derivatives. This led to the identification of TAT, a 19-O-acetyltransferase displaying high activity on tabersonine derivatives in yeast and in plants as compared to MAT. Furthermore, combining TAT with previously identified MIA biosynthetic enzymes ultimately allowed the engineered synthesis of unnatural tabersonine derivatives. Such a system thus constitutes a valuable tool to perform tailor-made decorations of the tabersonine scaffold yielding potential anti-cancer or anti-Alzheimer compounds (Lim et al., 2008; Frei et al., 2013; Kai et al., 2015; Chung et al., 2017) .
RESULTS

Efficient expression of MAT in yeast cells did not allow biotransformation of 19-hydroxylated tabersonine derivatives into acetylated products
To initiate the bioconversion of tabersonine into the rootspecific MIAs, yeast strains expressing T19H and MAT or MAT alone were first generated using autoreplicative plasmids bearing inducible promoters. Sequencing of the cloned cDNAs revealed that both gene sequences were strictly identical to the published ones (Laflamme et al., 2001; Giddings et al., 2011) . Galactose-induced transformed yeast cultures were then fed with tabersonine (125 lM) for 24 h and the resulting products were analyzed by UPLC-MS (Figure 2(a) ). T19H expression resulted in substantial bioconversion of tabersonine into 19-hydroxytabersonine (m/z 353). In contrast, no acetylated form of this compound (m/z 395) was observed when MAT was co-expressed along with T19H. In these cells, although 19-hydroxytabersonine was formed, it was not consumed ( Figure S1(a) ). As a control, we confirmed that MAT mRNAs accumulated (Figure 2(b) ) and MAT protein was present (Figure 2(c) ). Since MAT activity has never been reported to acetylate 19-hydroxytabersonine, assays were also performed with previously reported MAT substrates (Figure 1 ). Vincadifformine was properly hydroxylated by T19H into minovincinine, but no further conversion occurred suggesting that MAT did not acetylate minovincinine in yeast (Figure 2(a) ). Deacetylvindoline and h€ orhammericine were also tested; however, the expected acetylated products vindoline (m/z 457) and 19-acetylh€ orhammericine (m/z 411) were neither detected in the yeast culture medium (Figure 2(a) ) nor inside yeasts ( Figure S1(b) ). Due to the relatively high K m of MAT for MIAs (120 to 250 lM, Laflamme et al., 2001) , additional assays were conducted with 500 lM of tabersonine derivatives but again no acetylated products were observed (Figure S1(c) ). In addition, feeding yeast cells with acetylated MIAs such as vindoline did not reveal any endogenous esterase activity that could potentially hydrolyze acetylated products ( Figure S1(d) ). These results thus prompt us to search for alternative BAHDs in C. roseus that may efficiently acetylate 19-hydroxytabersonine derivatives in vivo.
RNA-seq analyses combined to expression correlation studies with T19H led to identification of BAHD acyltransferase candidates expressed in roots While we first established that roots from C. roseus had a high level of 19-O-acetyltransferase activity, which is in agreement with their MIA content ( Figure S2(a-c) ), analysis of the previously generated transcriptomic data from this organ revealed a low abundance of MIA biosynthetic transcripts ( Figure S3 (a) and Figure S4 ). As these resources might not be adequate to conduct sensitive gene expression correlation studies, we initiated adventitious roots from C. roseus stems to generate additional transcriptomic resources ( Figure S2(b) ). A uniform population of young roots was conveniently collected to perform RNA sequencing. Following transcriptome reconstitution and analysis ( Figure S4 -ERR2112587 accession number, Table S1), we confirmed the high expression of MIA biosynthetic genes in adventitious roots ( Figure S3(b) ).
With a transcriptomic data set including adventitious root (this study), leaves (Dug e de Bernonville et al., 2017) and other available data sets, Pearson correlation coefficients (PCC) with T19H were calculated on expression levels obtained after mapping reads to C. roseus transcripts predicted from genome sequence (Kellner et al., 2015a) (Figure 3(a) ). Within the members of the BAHD acyltransferase family retrieved from this analysis, five potential candidates displayed a strong correlation with T19H (PCC >0.8): CRO_T005210, CRO_T005211, CRO_T005215, CRO_T020281 and CRO_T0022100 as well as MAT (CRO_T005213) that exhibited the weaker correlation (0.82). As expected, DAT (CRO_T020280), involved in leaf alkaloid metabolism, was negatively correlated (PCC = À0.38). Interestingly, all BAHD candidates but CRO_T0022100 were located within two distinct gene clusters ( Figure S5 ). Transcript profiling showed that the new BAHD candidates were mainly expressed in roots with higher level in the adventitious root (Root_AS) sample, in contrast to DAT expressed in leaves (Figure 3(b) ). We noted that MAT and CRO_T022100 transcripts were also present in leaves and induced by methyljasmonate treatments but not the other candidates. Overall, the expression profiles of the BAHD candidates were similar to that of T19H reinforcing their potential involvement in tabersonine derivative acetylation. Phylogenetic analyses revealed that these candidates belong to clade IIIa of the BAHD superfamily that includes many enzymes involved in alkaloid metabolism ( Figure S6 and Table S3 ). Except for the closely related CRO_T005210 and CRO_T020281 (91%), the newly identified BAHDs shared an average amino-acid identity of 48-56% and a similar level of identity with DAT and MAT (48-54%) while MAT has a higher similarity with DAT (77%) ( Figure S7 and Table S2 ). All these proteins also conserved the characteristic amino-acid motifs of BAHD acyltransferases: the HXXXD residues in the central part of the protein shown to be involved in reaction catalysis; and at the C-terminal end, the DFGWG motif suggested to play a structural role (Figure S7; Ma et al., 2005; D'Auria, 2006) . However, a mutation of the tryptophan residue in the highly conserved DFGWG motif was observed in MAT, CRO_T020281 and CRO_T005210. Finally, consensus type I peroxisome targeting sequences (PTS1) were also detected in the last three residues of CRO_T005210, CRO_T005211, CRO_T020281 and CRO_T020282 strongly suggesting that these proteins can be addressed to peroxisomes (Reumann et al., 2016) . Such subcellular compartmentation was confirmed for CRO_T005210 by expression of YFP fusion proteins in C. roseus cells ( Figure S8 ).
CRO_T005215 encodes a functional tabersonine derivative 19-O-acetyltransferase
To test the capacity of BAHD candidates to acetylate 19-hydroxy tabersonine derivatives, proteins were coexpressed with T19H or expressed individually in yeast, except for CRO_T05211 that we were not able to amplify probably due to a very low level of expression (Figure 3(b) ). No conversion of 19-hydroxytabersonine, h€ orhammericine and minovincinine was observed with CRO_T005210, CRO_ T022100, CRO_T020281, MAT and DAT. By contrast, co-expression of CRO_T005215 caused a pronounced consumption of these compounds (Figures 3(c) and Figure S9 (a-c)) accompanied by the appearance in the culture medium of products displaying retention times and mass-to-charge ratios consistent with 19-acetyltabersonine (m/z 395), 19-acetylh€ orhammericine (m/z 411) or echitovenine (m/z 397) (Figure 1) . Furthermore, we noted that deacetylvindoline was acetylated by DAT, but not by the other enzymes, suggesting the existence of marked substrate specificities for the tested BAHD. To firmly identify the nature of the modification catalyzed by CRO_T005215, nuclear magnetic resonance (NMR) spectroscopy of the product confirmed the attachment of the acetyl group to C-19 ( Figure S10 ). This establishes the regioselectivity of CRO_T005215 in the 19-O-acetylation of 19-hydroxytabersonine and most likely for 19-O-acetylation of h€ orhammericine and minovincinine as well. As a consequence, CRO_T005215 was named tabersonine derivative 19-O-acetyltransferase (TAT; GenBank accession number KU821123).
In vitro, recombinant MAT and TAT acetylate 19-hydroxytabersonine derivatives but TAT displays a much higher catalytic efficiency
In order to gain insight into TAT enzymatic specificities and the lack of MAT in vivo activity, the biochemical properties of both enzymes were subsequently evaluated following their heterologous expression and purification in E. coli ( Figure S11(a) ). In contrast to in vivo assays in yeast, recombinant purified MAT protein displayed acetyltransferase activity in vitro, as previously reported (Table 1; Laflamme et al., 2001) . As expected, TAT recombinant protein was also active in vitro. Kinetic parameters of the recombinant proteins were determined with acetyl-CoA as acyl donor and with various acyl acceptors: 19-hydroxytabersonine, h€ orhammericine, minovincinine, deacetylvindoline and also non-related MIA compounds such as spermidine, quercetin, cyanidin, naringenin and caffeic acid (Table 1) . First, we noted that MAT and TAT were not able to acetylate compounds outside of the MIA family, suggesting that both enzymes are specific to 19-hydroxytabersonine derivatives. In agreement, deacetylvindoline, a 16-hydroxylated tabersonine derivative, was not an acetyl acceptor. Furthermore, steady-state analyses highlighted differences in kinetic parameters of TAT and MAT. For instance, TAT exhibited a low K m (9 lM) for minovincinine while it reached 58 lM and 78 lM for h€ orhammericine and 19-hydroxytabersonine, respectively. By contrast, MAT displayed nearly similar K m values for the three compounds ranging from 21 lM for minovincinine to 40 lM for 19-hydroxytabersonine. Most importantly, TAT exhibited kcat values around 50-fold (19-hydroxytabersonine), 65-fold (minovincinine) and up to 230-fold (h€ orhammericine) higher than those of MAT. Accordingly, TAT catalytic efficiencies (kcat/K m ) were much higher than MAT, from 20-fold (19-hydroxytabersonine), 80-fold (h€ orhammericine) to 200-fold (minovincinine). In addition, specificity for CoA donors was also investigated by testing acylation of 19-hydroxytabersonine with acetylCoA, benzoyl-CoA, cinnamoyl-CoA, p-coumaroyl-CoA, caffeoyl-CoA, feruloyl-CoA and sinapoyl-CoA donors (Table 1) . In our experimental conditions, TAT and MAT exclusively used acetyl-CoA as a donor, establishing their high specificity towards the acyl donor. Both enzymes exhibited similar K m values (around 5 lM) but again TAT differed from MAT by a 100-fold higher kcat.
Interestingly, mutation analyses revealed that the tryptophan to leucine substitution in the highly conserved DFGWG motif of TAT, and the reverse substitution to establish the conserved motif in MAT, have no consequence on TAT and MAT activities, respectively ( Figure S7 and Figure S11 (b, c)). Furthermore, incubating 19-acetyltabersonine with CoA revealed that neither TAT and MAT nor their mutated versions carry out deacetylation reaction in contrast to the well characterized vinorine synthase (VS) from Rauwolfia serpentina (Bayer et al., 2004) (Figure S11 (d) ). Taken together, our results demonstrate that both TAT and MAT specifically acetylate tabersonine derivatives in vitro in the forward reaction with TAT exhibiting a much higher catalytic efficiency. The lack of in vivo activity of MAT in recombinant yeast may be related to its low catalytic activity towards tabersonine derivatives.
TAT displays gene expression features relevant to a prominent role in tabersonine acetylation in roots of C. roseus
To study the function of TAT in planta, we investigated the expression profile of TAT and MAT in C. roseus organs.
Since 19-hydroxylation occurs necessarily before 19-Oacetylation, the expression of the specific BAHD is expected to be correlated to both T19H expression profile and to 19-O-acetylated MIA accumulation.
We first confirmed that TAT transcripts followed an expression pattern similar to T19H with a main accumulation in roots in agreement with our transcriptomics results (Figure 4(a) ). Such expression profiles differed from those of MAT and DAT for which transcripts were also detected or mainly accumulated in leaves, respectively. In addition, we also compared TAT and MAT expression in hairy roots and in adventitious roots induced from stem cuttings. Biosynthesis of tabersonine derivatives was active in adventitious roots but downregulated in hairy roots (Figure 4(b) ). A single acetylated tabersonine derivative was present in adventitious roots, namely echitovenine, while it was barely detectable in hairy roots. While TAT was expressed in both types of roots, the 50-fold up-regulation of MAT in hairy roots and the low expression in adventitious roots appear to be disconnected with the acetylated tabersonine metabolism in these organs (Figure 4(c) ). These expression profiles thus argue for a prominent role of TAT in 19-O-acetylation of tabersonine derivatives in C. roseus roots compared to MAT. Such a concerted reaction of T19H and TAT is also facilitated by their close subcellular compartmentation in the cell relying on the anchoring of T19H to the endoplasmic reticulum (ER) and on the nucleocytosolic distribution of TAT contributing to product/substrate channeling as suggested by subcellular localization studies of fusion to fluorescent proteins ( Figure S12(a-u) ). His-tagged TAT and MAT were expressed in E. coli, purified and assayed for acylation activity. Kinetic parameters were determined as described under the experimental procedure section. The results are the mean of three independent assays. '-', no detectable activity.
We next attempted to downregulate TAT gene expression in C. roseus roots by virus-induced gene silencing (VIGS). Although VIGS is an efficient system to downregulate gene expression in leaf, TAT expression in roots was found to be recalcitrant to downregulation ( Figure S13 (a-f)). As a consequence, we conducted in planta assays by overexpressing TAT and MAT in leaves of Nicotiana benthamiana ( Figure 5 ). After cloning TAT and MAT coding sequences into the binary plasmid pCAMBIA1302 to express the TAT-GFP and MAT-GFP fusion proteins, recombinant plasmids or empty pCAMBIA1302 were individually agroinfiltrated in young leaves. Analysis of GFP fusion protein expression confirmed that the number of cells producing GFP, TAT-GFP and MAT-GFP were almost equivalent suggesting no biases in levels of protein expression ( Figure 5(a-f) ). Both TAT-GFP and MAT-GFP fusion proteins also exhibited a similar subcellular localization and a similar size as revealed by western blot analysis ( Figure 5(g-l) ). For studying acetyltransferase activity, leaf disks from each transformed area were excised and vacuum-infiltrated with buffer containing minovincinine and acetyl-CoA. In these conditions, only the TAT-GFP fusion protein was shown to acetylate minovincinine while GFP and MAT-GFP did not ( Figure 5(k) ). Such specificity was confirmed by conducting a similar assay in yeast, which also demonstrated that substrate accessibilities were not limiting MAT activity ( Figure S14(a-n) ). All the results thus suggest that TAT displays a prominent role in 19-O-acetylation of tabersonine derivatives in planta and potentially constitutes a promising tool for the metabolic engineering of the MIAs from C. roseus roots.
TAT allows metabolic engineering of yeast for production of unnatural MIAs
In planta, leaf and root have distinct metabolisms of tabersonine as a result of organ-specific expression of several genes involved in the leaf-borne vindoline pathway and in 19-acetyltabersonine/19-acetylh€ orhammericine/echitovenine pathways in roots. We hypothesized that combining selected enzymes from these pathways in a yeast expression platform might allow the production of non-natural MIAs.
In the vindoline pathway, tabersonine is subjected to two distinct regio-specific modifications: (i) C16 hydroxylation and methylation by T16H2 and 16OMT to form (c) The relative amounts of TAT and MAT transcripts were quantified by qPCR. Adventitious roots (dark gray) and hairy roots (light gray) were extracted simultaneously for both alkaloid and RNA. Data represent mean AE standard error (SE) of three technical replicates performed individually on six samples of each organ type. RPS9 and ERF1a were used as reference genes.
16-methoxytabersonine; (ii) C2-C3 epoxidation by tabersonine 3-oxidase (T3O) yielding to 16-methoxytabersonine epoxide/imine alcohol when this reaction is performed on 16-methoxytabersonine or to tabersonine epoxide when T3O acts directly on tabersonine (Levac et al., 2008; Besseau et al., 2013; Kellner et al., 2015b; Qu et al., 2015) (Figure 6(a) ). We first attempted to combine C3 (leaf specific) and C19 (root-specific) modifications of tabersonine. When expressed separately, both T19H and T3O were able to convert tabersonine into the expected compounds that displayed the same m/z (353) but different retention times (Figure 6(b) ). However, in yeasts co-expressing both T19H and T3O, neither 19-hydroxy tabersonine epoxide nor the corresponding imine alcohol that can be spontaneously formed following epoxide opening (predicted m/z 369) were detected. Careful examination of the reaction products showed the presence of 19-hydroxytabersonine and the preferential accumulation of tabersonine epoxide confirming that both T19H and T3O were active but also demonstrated that these two modifications of tabersonine cannot occur simultaneously on the same molecule. We then tested combination of C16 (leaf specific T16H2 and 16OMT) and C19 (root-specific T19H and TAT) modifications of tabersonine (Figure 6(a, c) ). As compared to control cells, we first established that co-expressing T16H2 and 16OMT led to the expected successive conversion of tabersonine into 16-hydroxytabersonine (m/z 353) and 16-methoxytabersonine (m/z 367). Interestingly, addition of T19H to this strain induced the formation of a more hydrophilic compound with m/z 383 consistent with the expected 16-methoxy-19-hydroxytabersonine. Furthermore, the addition of the TAT gene to the system resulted in synthesis of a more hydrophobic product (m/z 425) that is consistent with the acetylation of 16-methoxy-19-hydroxytabersonine to 16-methoxy-19-acetyltabersonine (Figures 6(a, c) and S15). Besides accumulation of several biosynthetic intermediates, the final conversion into this last compound reached around 10% of the starting amount of tabersonine after 16 h of incubation with the yeast culture (around 106 AE 20 lg.g DW
À1
). Interestingly, all the biotransformed MIAs and biosynthetic intermediates were secreted in the culture medium leaving behind only trace levels within
(k) (l) Figure 5 . TAT but not MAT acetylates minovincinine in leaves of N. benthamiana.
(a-j) GFP (a, b), TAT-GFP (c, d, g, h) and MAT-GFP (e, f, i, j) were transiently overexpressed in N. benthamiana leaves through agrotransformations during 5 days before observation. Bars, 100 lm (a-f); 10 lm (g-j). DIC, differential interference contrast.
(k) Infiltrated areas expressing the fusion proteins were harvested and infiltrated with minovincinine and acetyl-CoA during 5, 120 or 720 min before estimation of acetyltransferase activity through echitovenine quantification.
(l) TAT-GFP and MAT-GFP were detected by western blot analysis performed using anti-GFP antibodies.
yeasts ( Figure S1 (e)). Altogether, these results strongly suggest that tabersonine can be simultaneously decorated on the distal regions C16 and C2-C3, to form 16-methoxytabersonine epoxide, which is naturally observed in the vindoline pathway, C16 and C19 to generate the new-to-C. roseus compound 16-methoxy-19-hydroxytabersonine, and that simultaneous decorations of C2-C3 and C19 are not compatible. Similar conversions were obtained when vincadifformine or h€ orhammericine are used as the starting substrate leading to the synthesis of several unnatural MIAs including 16-methoxy-echitovenine from vincadifformine and 16-methoxy-19-acetylh€ orhammericine from h€ orhammericine ( Figure S16 (a-c) and Figure S17(a, b) ). Our results therefore demonstrate that MIA biosynthetic enzymes can be used as tools to synthesize tailor-made MIAs via mixing distinct enzyme modules. As such, the synthesis of 16-methoxy-19-acetyltabersonine in yeast through the expression of four plant genes constitutes a proof of principle for metabolic engineering of C. roseus root MIAs in a heterologous organism and is also an example of a streamlined enzyme combination allowing a controlled reorientation of the synthetic fluxes.
DISCUSSION MAT has minor or indirect role in 19-O-acetylation of tabersonine derivatives
Over the last 5 years, the elucidation of the MIA biosynthetic pathway in C. roseus has progressed tremendously and has allowed the development of bioengineering strategies leading to the production of MIAs in heterologous organisms such as N. benthamiana or S. cerevisiae (Courdavault et al., 2014; Miettinen et al., 2014; Brown et al., 2015; Qu et al., 2015) . Most of these advances essentially apply to the early steps of MIA synthesis up to strictosidine, the universal MIA precursor, or to MIAs restricted to the aerial parts of the plant. By contrast, the characterization of MIA biosynthesis in roots has retained only limited attention and no metabolic engineering approach has emerged. Up to now, two root-specific enzymes have been identified, T19H performing the hydroxylation of tabersonine (Giddings et al., 2011) and MAT, a BAHD described to catalyze the acetylation reaction in the synthesis of 19-Oacetylhorhammericine and echitovenine (Laflamme et al., 2001) . However, all our results tend to demonstrate that MAT only displays a very low catalytic efficiency in vitro towards root tabersonine derivatives (Table 1) in agreement with Laflamme et al. (2001) . Such a low efficiency is unlikely to arise from uses of an incorrect acyl donor since the recombinant MAT has a low K m towards acetyl-CoA, precluding other possible reactions of acylation that could lead to other MIAs such as 16-methoxyechitovenilline, acylated by trimethoxy benzoyl in Alstonia venenata (Majumder et al., 1979) . The low catalytic efficiency of MAT also does not result from the absence of tryptophan in the DFGWG domain since restoration of this amino acid in a mutant MAT does not improve catalytic activity, in contrast to the pronounced effect of the D mutation (xFGWG) on BAHD activity ( Figure S7 and Figure S11 (c); Bayer et al., 2004; Tuominen et al., 2011) . Furthermore, this low catalytic efficiency in vitro correlates with the lack of detectable MAT activity in vivo as established in yeast and N. benthamiana (Figure 2 , 5 and Figure S14 ). While we cannot exclude that our in vivo assays were not sensitive enough to measure rare acetylations, we established that this lack of activity did not result from protein degradation or altered subcellular localization as revealed by western blot analysis and GFP imaging in yeast or N. benthamiana cells (Figures 5 and S14 ). It neither resulted from high endogenous esterase activities that could overcome the low acetyltransferase activity of MAT since no de-esterification of acetylated MIAs has been measured ( Figure S1(d) ).
Although MAT inactivity in vivo may result from inhibitions caused by the abundant presence of other proteins in the whole cell as previously suggested (Magnotta et al., 2007) , MAT low catalytic activity in vitro might also represent the persistence of an ancient acyltransferase activity that evolved to acetylate other yet unknown MIAs in planta exhibiting a tabersonine-or other-type backbone. Altogether, these results thus strongly suggest that MAT has a minor or no direct role in acetylation of tabersonine derivatives in roots of C. roseus.
TAT displays biochemical properties and gene expression profiles consistent with a prominent role in tabersonine derivative acetylation
Through the development of a transcriptomic resource from C. roseus adventitious roots ( Figure S3 and Figure S4 ), analysis of gene expression correlation led to the identification of TAT (CRO_T005215) as an enzyme catalyzing the 19-O-acetylation of tabersonine derivatives in vivo (Figures 3(c) , 5, S9 and S12). At the biochemical level, TAT displays a K m value in the lM range like the other BAHDs involved in MIA biosynthesis such as DAT and VS of R. serpentina, (this work; Laflamme et al., 2001; Bayer et al., 2004) . However, the recombinant enzyme has marked differences in affinity for the tested substrates with a lower K m for minovincinine (9 lM) and a roughly six-fold to eight-fold higher K m for 19-hydroxytabersonine and h€ orhammericine. This indicates that the C6-C7 configuration of the tabersonine backbone has marked consequences on TAT enzyme affinity. Presence of an epoxide or a double bound at this position probably changes substrate conformation and/or increases steric hindrance in the C5-C6 region resulting in affinity decreasing and by consequence in a marked preference for saturated bond. Such kind of specificity has already been reported for the acetyl-ajmalan esterase that hydrolyzes the 17-O-acetylated norajmaline from R. serpentina and strictly requires a saturated 19-20 bond (Polz et al., 1987) . This substrate preference supports the accumulation profile of 19-O-acetylated tabersonine derivatives in the analyzed root samples since only echitovenine, resulting from minovincinine acetylation, was detected (Figure 4(b) ).
While we were not able to confirm TAT functions using VIGS due to the inefficiency of this approach in roots (Figure S13) , its high catalytic efficiency in vitro and its capacity to work in planta and in other distinct heterologous organisms (Table 1 and Figure 5 , Figure S13 and Figure S14 ) collectively provide strong evidence of a prominent role for TAT in MIA biosynthesis in C. roseus roots. Accordingly, TAT gene expression profile is very similar to T19H and follows tabersonine root metabolite accumulation (Figure 4(a, b) ) in accordance with the fact that genes belonging to a same pathway often exhibit similar expression profiles correlated to MIA accumulation Dug e Bernonville et al., 2015; Parage et al., 2016) .
Combinatorial biosynthesis of C. roseus root-type MIAs in yeast
The identification of TAT enabled development of the metabolic engineering of C. roseus root-type MIAs in yeast. Feeding tabersonine, vincadifformine or h€ orhammericine as starting substrates to engineered yeast yielded known as well as unnatural MIAs (Figures 6, S16 and S17). First, by combining enzymes from the vindoline (leaf) and root-alkaloid pathways, we showed that regiospecific modifications of tabersonine may also involve conformational specificities of close positions since only the distal C16 hydroxylation/methylation and C2-C3 epoxidation or C16 hydroxylation/methylation and C19 hydroxylation/acetylation can occur simultaneously on the same molecule. This yeast engineering approach also demonstrated that substrate promiscuities of T16H2, 16OMT, T3O, T19H and TAT allow new opportunities to synthesize unusual or new-tonature compounds. While echitoveniline, 16-methoxyechitoveniline or 16-methoxyechitovenidine have already been identified in leaves and fruits of Alstonia venenata, the synthesis of 16-methoxyechitovenine resulting from the combination of T16H2, 16OMT, T19H and TAT has never been observed in nature (Majumder et al., 1979;  Figure S16 ). Interestingly, precursors have been described in Vinca minor including ervinceine (16-methoxyvincadifformine) or minovincinine (thus hydroxylated at C19) but no mixed forms or acetylated compounds have been observed, likely because of the lack of a close ortholog of TAT in this plant (Demessie et al., 2017 ; closest ortholog in Vinca minor share around 30% identify with TAT). By contrast, the absence of these compounds in C. roseus plants largely results from the organ-specificity of gene expression of T16H2/16OMT and T19H/TAT in leaves and roots, respectively. However, cell suspension cultures have been shown to accumulate 16-methoxy-19-acetyltabersonine, 16-methoxy-19-hydroxytabersonine or lochnerinine (16-methoxylochnericine) as a consequence of a possible alteration of gene expression profile in dedifferentiated cells Kutney et al., 1980) . This is also potentially applicable to 16-methoxy-19-acetylh€ orhammercine and to the new compounds resulting from T3O activity such as h€ orhammericine epoxide and vincadifformine epoxide ( Figure S17(a) ). Further elucidation of the MIA biosynthetic pathway and its organization at the cellular and subcellular levels in C. roseus and other MIA-producing Apocynaceae will contribute to expand the tool-box for MIA genetic engineering. The combinatorial biosynthesis of MIAs related to tabersonine would allow quick access to diverse analogs for biological evaluation. For example, tabersonine has been reported to be a lead compound in the treatment of Alzheimer's disease by disrupting amyloid beta (Ab) fibrils and ameliorates Ab aggregateinduced cytotoxicity (Kai et al., 2015) . In addition, more highly oxidized tabersonine congeners such as the jerantinines have been shown to possess potent anti-cancer activities and merit further study (Lim et al., 2008; Frei et al., 2013; Chung et al., 2017) .
In conclusion, we identified in this work a new BAHD enzyme that catalyzes acetylation of root-type tabersonine derivatives in C. roseus, thus allowing the refinement of the MIA biosynthetic pathway and also the opportunity to establish the metabolic engineering of periwinkle root-type MIAs ultimately leading to the synthesis of unnatural MIAs. This discovery enables controlled decorations of vincadifformine, tabersonine or h€ orhammericine to enrich the panel of compounds that can be used for downstream chemical modifications as described with mutants of MIA biosynthetic enzymes (Bernhardt et al., 2007) or to broaden their intrinsic pharmaceutical properties as previously described for vincadifformine derivatives (Mustopha et al., 2006; Cao et al., 2012) .
EXPERIMENTAL PROCEDURES Chemicals
Tabersonine was purchased from ChromaDex (USA). H€ orhammericine was purified from C. roseus according to Giddings et al. (2011) . Vincadifformine was prepared by the hydrogenation of tabersonine as described in Zhao and Andrade (2013) . Acetyl-CoA and CoA were purchased from Sigma while other CoA-esters were chemically prepared according to previously published methods (St€ ockigt and Zenk, 1975; Negrel and Smith, 1984; Elejalde-Palmett et al., 2015) ..
Plant growth conditions
C. roseus (cultivar Apricot Sunstorm) were grown in a greenhouse at 28°C under a 16h light/8h dark cycle and were used for all experiments except VIGS assays that were conducted on the Little Bright Eyes cultivar as described in Carqueijeiro et al. (2015) . Hairy roots were propagated as described in Courdavault et al. (2005) . N. benthamiana were cultivated in a greenhouse at 24°C with a photoperiod of 16 h/8 h light/dark cycle.
Development of water-induced adventitious roots
Water-induced adventitious roots were generated by immersing freshly cut stems of 6-8-week plantlets (Apricot Sunstorm cultivar). Leaves from the last 10 cm of stem were removed before immersion whereas upstream leaves were maintained to allow photosynthesis. Plantlets were placed in greenhouse (28°C, 16 h/ 8 h photoperiod) and water was changed every 3 days. First adventitious roots begin to develop on stems almost 5 days after immersion and reach a 5-cm length around 2 weeks later. Apical parts of roots (1 cm) were harvested for RNA sequencing and metabolites quantification.
RNA-seq procedures
RNAs were extracted using TRIzol (Life Technologies) according to Dug e de Bernonville et al. (2017) . RNA-seq library preparation and high-throughput sequencing were performed by Eurofins using Illumina HiSeq 2000/2500 with chemistry v3.0 in the paired mode. The adventitious root sample was deposited on EBI ENA under accession number ERR2112587 (study PRJEB22378).
De novo transcriptome assembly and abundance estimation
Individual root transcriptomes were assembled with Trinity v2.1.1 after applying an in silico normalization step (with a max_cov value of 50) (Haas et al., 2013) as described in the method section of Figure S3 .
Co-expression of T19H and BAHDs in yeast for identification of tabersonine derivative acetyltransferase activity
Full length open reading frames of T19H, MAT, CRO_T005210, TAT (CRO_T005215), CRO_T022100, CRO_T020281 and DAT were amplified using specific pairs of primers (Table S4 ). These primer couples have been designed to include restriction sites at their extremities to allow cloning of the T19H amplicon into pYEDP60, MAT, TAT (CRO_T005215) and CRO_T022100 into pESC-HIS and DAT, CRO_T005210 and CRO_T020281 into pESC-TRP. Recombinant plasmids were independently used to transform the S. cerevisiae strain WAT11 expressing the A. thaliana NADPH P450 reductase 1 (Pompon et al., 1996) . Each BAHD expressing vector was also co-transformed with the T19H expressing vector. Yeasts were grown in 10 mL of CSM medium (Yeast Nitrogen Base 0.67%, dextrose 2%, drop-out mix without adenine and uracil 0.05%) until reaching the stationary phase of culture and prior being harvested by centrifugation. Protein expression was induced by cultivating the harvested yeast in 50 mL of YPGal medium (2% bacto peptone, 1% yeast extract, and 2% galactose) for 6 h as described in Parage et al. (2016) .
BAHD functional assays in yeast and large scale product synthesis BAHD functional assays in yeast were performed by feeding 175 ll of galactose-induced recombinant yeast strains with 125 lM or 500 lM of tabersonine, vincadifformine (for strains expressing T19H and one BAHD), h€ orhammericine and deacetylvindoline (for strains expressing a BAHD without T19H), during 16 h at 30°C under continuous shaking. Reactions were centrifuged (10 min; 5000 g) and supernatants were collected before adding three methanol volumes. Following homogenization with vortex, reactions were centrifuged (15 min; 25 000 g) before subsequent UPLC-MS analysis. For large scale product synthesis, 30 mL of the T19H/TAT expressing yeast strain were grown, induced and fed with 2 mg of tabersonine during 24 h at 30°C. Following centrifugation (10 min; 5000 g), supernatant was collected and alkalinized to pH 9 using NaOH. One volume of dichloromethane was then added and the resulting solution homogenized with vigorous shaking for phase separation. The organic phase was collected and evaporated. The extraction of alkaloids from the alkalinized supernatant was performed twice. Reaction products were finally re-suspended in methanol before analysis.
Production of recombinant TAT and MAT in E. coli and steady-state enzyme kinetics Recombinant TAT and MAT were produced by amplifying their coding sequences using primers T005215-Bam-for/T005215-Bamrev and MAT-Bam-for/MAT-Bam-rev (Table S4 ) and cloning the resulting polymerase chain reaction (PCR) products into pQE-30 (Qiagen) and pRSET-A (Invitrogen), respectively. Recombinant plasmid was co-transformed in E. coli BL21(DE3) with pUBS520 expressing the rare arginine encoding codons (AGA, AGG). Transformed cells were cultivated until exponential growth (Abs 595 nm = 0.5) before inducing protein expression by adding 1 mM IPTG for 4 h at 28°C. Recombinant proteins were purified using a Co 2+ matrix according to the manufacturer's protocol (Talon Resin metal ion, Clontech) and subsequently concentrated and dialyzed against phosphate buffer (100 mM pH 7.5) using centricon (30 kDa cut-off, Millipore). 10% glycerol was finally added before freezing aliquoted protein in liquid nitrogen. Enzymatic assays were conducted at 30°C in 20 lL final volume containing HEPES buffer (100 mM pH 7.6 supplemented with 2 mM of ascorbic acid) and various amounts of acceptor/donor substrates. Kinetic parameters were measured using 1 lg of recombinant MAT/mMAT for 2 min or 0.1 lg of recombinant TAT/mTAT for 1 min with increasing amounts of 19-hydroxytabersonine, minovincinine, h€ orhammericine or deacetylvindoline (0, 1,2, 5, 10, 100, 250 or 500 lM) in the presence of 500 lM acetyl-CoA, and increase amounts of acetyl-CoA (0, 0.1, 0.5, 1, 10, 100, 500 or 800 lM) in the presence of 300 lM of minovincinine. Additional substrates were tested using 1 lg of recombinant proteins and 20 min incubation, including caffeic acid, quercetin, spermidine, and naringenin (10 or 200 lM) as acceptors in the presence of 500 lM acetyl-CoA. CoA donors were also tested by incubating 1 lg of recombinant proteins with sinapoyl-CoA (60 lM), feruloyl-CoA (60 lM), and cinnamoyl-CoA (100 lM), in the presence of 300 lM of minovincinine. Finally, deacetyltransferase activities of the recombinant proteins were assayed with 19-O-acetyltabersonine (0, 50, or 500 lM) in the presence of 500 lM CoA. For each assay, reactions were stopped by adding one volume of methanol followed by vigorous shaking. For UPLC-MS analyses, four volumes of 0.1% formic acid in water were added. Solutions were vortexed and centrifuged for 10 min at 16 000 g before collecting 5 lL of the supernatant for injection.
UPLC-MS analyses
UPLC-MS analyses were conducted using equipment and condition described in Parage et al. (2016) 
Gene expression analysis (real-time RT-PCR)
Expressions of T19H, TAT, MAT and DAT were analyzed by realtime RT-PCR according to Parage et al. (2016) and Liscombe and O'Connor (2011) , using primers compiled in Table S4 , RPS9 and EF1a as endogenous reference genes and retro-transcribed RNAs from different C. roseus organs (including roots, stems, young and mature leaves -Apricot Sunstorm cultivar; adventitious roots and hairy roots).
Detection of proteins through western blot analysis
Proteins were extracted by grounding plant and yeast samples in liquid nitrogen and thawing in cold lysis buffer containing 100 mM Tris pH 7.5, 1 mM EDTA, 1 mM DTT, 1 mM PMSF, 1 mM MgCl 2 and protease inhibitors cocktail (Complete EDTA-free, Roche). Cell debris were removed by centrifugation at 25 000 g for 25 min at 4°C and protein concentrations were determined with Bradford reagent (Bio-Rad) before electrophoretic separation of 20 lg of proteins of each sample on SDS-PAGE (10%). Proteins were detected by western blot analysis according to Oudin et al. (2007) using the anti-GFP or anti-flag antibodies and the antimouse immunoglobulin alkaline phosphatase conjugate, diluted as recommended by the supplier (Covalab).
Analysis of TAT and MAT activities through agroinfiltration and leaf disk assays
Leaf disc assays were performed according to H€ ofer et al. (2013) with some modifications. For transient expression of TAT and MAT in N. benthamiana leaves, TAT and MAT coding sequences were first amplified using primers TAT-YFP-for/TAT-YFP-rev and MAT-YFP-for/MAT-YFP-rev (Table S4) , digested by SpeI and cloned into the binary vector pCAMBIA1302 to express the TAT-GFP and MAT-GFP fusion proteins. Agrobacterium tumefaciens strain GV3101 transformed with recombinant or empty vectors were co-infiltrated with A. tumefaciens transformed with pBin-P19 in young leaves of 5-week-old N. benthamiana plants. At 5 days post-infiltration, the presence of the proteins (GFP, MAT-GFP and TAT-GFP) was confirmed by GFP fluorescence monitoring as described in subcellular localization studies. Two centimeter diameter discs (around 0.15 to 0.3 g) were excised from the infiltrated leaves and placed in 10 mL 100 mM HEPES buffer pH 7.6 containing ascorbic acid 2 mM, acetyl-CoA 500 lM and minovincinine 300 lM, exposed to vacuum (50 mBar), and placed in a semi-dry Petri dish, for 120 min or 720 min in the dark at 24°C. Leaf discs were than lyophilized and alkaloids extracted and quantified by LC-MS as described above.
Combinatorial synthesis of MIAs through co-expression of leaf and root MIA biosynthetic enzymes in yeast Bioconversions of tabersonine, vincadifformine and h€ orhammericine into unusual or new-to-nature compounds were achieved through co-expression of leaf and roots MIA biosynthetic enzymes in yeast. For these experiments, TAT and T19H cDNAs were subcloned into the SpeI and BamHI restriction sites of the pESC-TRP yeast expression vector (pESC-TRP-T19H/TAT), respectively, after amplification of their coding sequences using primers compiled in Table S4 . pESC-TRP-TAT and pESC-TRP-T19H plasmids were also created accordingly. 16OMT and tabersonine 3-oxidase (T3O) were amplified with primers 16OMT-for/16OMT-rev and T3O-for/ T3O-rev (Table S4 ) and cloned into the BamHI or SpeI restriction sites of pESC-LEU to generate the pESC-LEU-16OMT and the pESC-LEU-T3O vectors. Both cDNA were also cloned into a same plasmid to generate pESC-LEU-16OMT/T3O. T16H2 was expressed using the pYeDP60-T16H2 plasmid as described in Besseau et al. (2013) . Recombinant plasmids were transformed into the WAT11 yeast strain to express T3O alone (pESC-LEU-T3O vector); T19H and T3O (pESC-TRP-T19H; pESC-LEU-T3O vectors); T16H2, 16OMT and T3O (pYeDP60-T16H2, pESC-LEU-16OMT/T3O vectors); T16H2, 16OMT and TAT (pYeDP60-T16H2, pESC-LEU-16OMT and pESC-TRP-TAT vectors); T16H2, 16OMT, T19H and TAT (pYeDP60-T16H2, pESC-LEU-16OMT and pESC-TRP-T19H/TAT vectors). Transformed yeasts were grown in 10 mL of CSM medium (Yeast Nitrogen Base 0.67%, dextrose 2%, drop-out mix without adenine and uracil 0.05% for pYeDP60 plasmid selection, without tryptophan for pESC-TRP plasmid selection or leucine for pESC-LEU plasmid selection) and induced as described above. Bioconversions were achieved by feeding recombinant yeasts with 125 lM of tabersonine, vincadifformine or h€ orhammericine and quantified as described in the BAHD functional assays in yeast section.
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